Tag: Lu-177 Octreotate
First U.S. Center to Enroll Patients in International, Multicenter Clinical Trial of Lu-177 Octreotate
November 20, 2012
Excel Diagnostics and Nuclear Oncology Center in Houston, Texas, is the first center in the United States to start recruiting patients in a multicenter randomized clinical trial of Lu-177 Octreotate in patients with progressive midgut carcinoid. …
READ MORE